Bone Biologics Corporation (BBLGW)
Bone Biologics Corporation, a medical device company, focuses on bone regeneration in spinal fusion using the recombinant human protein in the United States.
$8.00+0.00%
StockGlow Score
Bearish
BearishBullish
1 year ago-33.3%
The outlook
Bone Biologics Corporation currently reads as bearish based on below its 50- & 200-day averages, 4% of the way from its 52-week low to high. This is a snapshot of current market data, not a forecast.
What’s behind the score
Price trendBelow its 50- & 200-day averages
52-week range4% of the way from its 52-week low to high
Market cap
—
52-wk high
$35.95
52-wk low
$6.80
50-day avg
$14.20
200-day avg
$18.07
Trailing P/E
—